HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Indira K Hewlett Selected Research

Infections

3/2012Sensitive detection assays for influenza RNA do not reveal viremia in US blood donors.
2/2012Anthrax edema toxin impairs clearance in mice.
8/2010Characterization of immune responses to capsid protein p24 of human immunodeficiency virus type 1 and implications for detection.
3/2007Antibodies against a multiple-peptide conjugate comprising chemically modified human immunodeficiency virus type-1 functional Tat peptides inhibit infection.
4/2006Monocytes-macrophages are a potential target in human infection with West Nile virus through blood transfusion.
4/2006Selective side-chain modification of cysteine and arginine residues blocks pathogenic activity of HIV-1-Tat functional peptides.
5/2002Involvement of integrin alphavbeta3 in the pathogenesis of human immunodeficiency virus type 1 infection in monocytes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Indira K Hewlett Research Topics

Disease

9HIV Infections (HIV Infection)
01/2019 - 05/2002
7Infections
03/2012 - 05/2002
2Acquired Immunodeficiency Syndrome (AIDS)
01/2014 - 08/2010
1Dengue (Dengue Fever)
11/2018
1Viremia
03/2012
1Human Influenza (Influenza)
03/2012
1Anthrax
02/2012
1Edema (Dropsy)
02/2012
1Osteosarcoma (Osteogenic Sarcoma)
09/2011
1Retroviridae Infections (Infection, Retrovirus)
09/2011
1Influenza in Birds (Avian Flu)
10/2010
1Persistent Infection
08/2010
1West Nile Fever
07/2007
1Kaposi Sarcoma (Kaposi's Sarcoma)
04/2006

Drug/Important Bio-Agent (IBA)

4AntigensIBA
01/2019 - 08/2010
3AntibodiesIBA
01/2019 - 03/2007
3Peptides (Polypeptides)IBA
08/2010 - 04/2006
2Biomarkers (Surrogate Marker)IBA
01/2019 - 08/2010
2GoldIBA
11/2018 - 10/2010
2VaccinesIBA
03/2007 - 04/2006
1EuropiumIBA
01/2019
1StreptavidinIBA
11/2018
1Silicon Dioxide (Silica)FDA LinkGeneric
01/2017
1RNA (Ribonucleic Acid)IBA
03/2012
1Virulence Factors (Pathogenicity Factors)IBA
02/2012
1Adenylyl Cyclases (Adenylyl Cyclase)IBA
02/2012
1edema factorIBA
02/2012
1Proteins (Proteins, Gene)FDA Link
02/2012
1Chemokine ReceptorsIBA
09/2011
1EpitopesIBA
08/2010
1N-acetyltalosaminuronic acid (NAT)IBA
07/2007
1Nucleic AcidsIBA
07/2007
1tat Gene Products (tat Protein)IBA
04/2006
1Neutralizing AntibodiesIBA
05/2002
1Human immunodeficiency virus 1 gp120 proteinIBA
05/2002
1IntegrinsIBA
05/2002
1Integrin alphaVbeta3IBA
05/2002

Therapy/Procedure

2Therapeutics
11/2014 - 01/2014
1Blood Transfusion (Blood Transfusions)
04/2006